Skip to main content
Journal cover image

Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans.

Publication ,  Journal Article
Ernst, A; Eberhardt, R; Wahidi, M; Becker, HD; Herth, FJF
Published in: Chest
March 2006

STUDY OBJECTIVES: Clopidogrel is often prescribed for primary or secondary prevention of cardiovascular disease and has been associated with unwanted bleeding events. After having shown that transbronchial biopsy can safely be performed in pigs receiving clopidogrel, we sought to determine whether routine clopidogrel use increases the risk of bleeding after transbronchial lung biopsy in humans. DESIGN: Prospective cohort study. PATIENTS AND INTERVENTIONS: Data were collected on 604 patients without underlying coagulation problems who underwent transbronchial lung biopsy over 13 months. Clopidogrel was not discontinued before biopsy in patients who were using it. Transbronchial biopsies were performed, and the incidence of bleeding and other complications among patients receiving clopidogrel was compared with that of other patients. RESULTS: The study was stopped early because the bleeding rate in the clopidogrel-only group (n = 18) was excessive (89% [16 of 18 patients] vs 3.4% [20 of 574 control subjects; p > 0.001] and also in the group receiving clopidogrel and aspirin (100% [12 of 12 patients] vs 3.4% among control subjects [p > 0.001]. Bleeding rates were significantly higher in the clopidogrel group for each degree of bleeding severity: mild (27% vs 1.5%), moderate (34% vs 1.5%), and severe (27% vs 0.3%; p > 0.001 for all comparisons). All 12 patients receiving both aspirin and clopidogrel had bleeding: moderate in 6 patients and severe in 6 patients. All bleeding was controlled by endoscopic means. There were no fatalities or need for blood transfusions in the patients enrolled in the trial. CONCLUSIONS: Clopidogrel use greatly increases the risk of bleeding after transbronchial lung biopsy in humans and therefore should be discontinued before bronchoscopy with biopsies. Aspirin exacerbates the effect of clopidogrel on bleeding.

Duke Scholars

Published In

Chest

DOI

ISSN

0012-3692

Publication Date

March 2006

Volume

129

Issue

3

Start / End Page

734 / 737

Location

United States

Related Subject Headings

  • Ticlopidine
  • Respiratory System
  • Prospective Studies
  • Platelet Aggregation Inhibitors
  • Male
  • Humans
  • Female
  • Clopidogrel
  • Bronchoscopy
  • Biopsy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ernst, A., Eberhardt, R., Wahidi, M., Becker, H. D., & Herth, F. J. F. (2006). Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest, 129(3), 734–737. https://doi.org/10.1378/chest.129.3.734
Ernst, Armin, Ralf Eberhardt, Momen Wahidi, Heinrich D. Becker, and Felix J. F. Herth. “Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans.Chest 129, no. 3 (March 2006): 734–37. https://doi.org/10.1378/chest.129.3.734.
Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJF. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest. 2006 Mar;129(3):734–7.
Ernst, Armin, et al. “Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans.Chest, vol. 129, no. 3, Mar. 2006, pp. 734–37. Pubmed, doi:10.1378/chest.129.3.734.
Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJF. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest. 2006 Mar;129(3):734–737.
Journal cover image

Published In

Chest

DOI

ISSN

0012-3692

Publication Date

March 2006

Volume

129

Issue

3

Start / End Page

734 / 737

Location

United States

Related Subject Headings

  • Ticlopidine
  • Respiratory System
  • Prospective Studies
  • Platelet Aggregation Inhibitors
  • Male
  • Humans
  • Female
  • Clopidogrel
  • Bronchoscopy
  • Biopsy